Brief: Aurinia Pharmaceuticals Inc - $34.4 Million In Net Revenue For Q1 Of 2023, Up 59%
04/05/2023 11:27
Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA PHARMACEUTICALS INC - $34.4 MILLION IN NET REVENUE
FOR
Q1 OF 2023, UP 59%
* AURINIA PHARMACEUTICALS INC - INCREASES 2023 REVENUE
GUIDANCE
RANGE TO $135 - $155 MILLION FROM NET PRODUCT SALES OF LUPKYNIS
* AURINIA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.18
Source text for Eikon: ID:nBw7J9Wfma
Further company coverage: AUPH.O
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death